We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 588 results
  1. mGlu2/3 receptor antagonists for depression: overview of underlying mechanisms and clinical development

    Triggered by the ground-breaking finding that ketamine exerts robust and rapid-acting antidepressant effects in patients with treatment-resistant...

    Article 30 January 2023
  2. Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies

    The desire to find a gold-standard therapy for depression is still ongoing. Develo** one universal and effective pharmacotherapy remains...

    Barbara Chruścicka-Smaga, Agata Machaczka, ... Andrzej Pilc in Pharmacological Reports
    Article Open access 07 November 2023
  3. mGlu2/3 Receptor Antagonists as Rapid-Acting Antidepressants

    Since the discovery of the robust and rapid-acting antidepressant effects of ketamine in patients with treatment-resistant depression, the...
    Chapter 2021
  4. Effects of the mGlu2/3 receptor agonist LY379268 on two models of disturbed auditory evoked brain oscillations in mice

    Cognitive impairment is a core feature of schizophrenia and is poorly addressed by currently available medication. This is partly because the...

    Oana-Daniela Dormann, Niklas Schuelert, Holger Rosenbrock in Translational Psychiatry
    Article Open access 06 May 2023
  5. Group I and group II metabotropic glutamate receptors are upregulated in the synapses of infant rats prenatally exposed to valproic acid

    Rationale

    Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by impaired social interaction and restricted/stereotyped...

    Simona D’Antoni, Sara Schiavi, ... Maria Vincenza Catania in Psychopharmacology
    Article Open access 14 September 2023
  6. Ceftriaxone and mGlu2/3 interactions in the nucleus accumbens core affect the reinstatement of cocaine-seeking in male and female rats

    Rationale

    The beta-lactam antibiotic ceftriaxone reliably attenuates the reinstatement of cocaine seeking. While the restoration of nucleus accumbens...

    Carly N. Logan, Allison R. Bechard, ... Lori A. Knackstedt in Psychopharmacology
    Article 07 May 2020
  7. Stepwise activation of a metabotropic glutamate receptor

    Metabotropic glutamate receptors belong to a family of G protein-coupled receptors that are obligate dimers and possess a large extracellular...

    Kaavya Krishna Kumar, Haoqing Wang, ... Brian K. Kobilka in Nature
    Article 17 April 2024
  8. G-protein activation by a metabotropic glutamate receptor

    Family C G-protein-coupled receptors (GPCRs) operate as obligate dimers with extracellular domains that recognize small ligands, leading to G-protein...

    Alpay B. Seven, **mena Barros-Álvarez, ... Georgios Skiniotis in Nature
    Article 30 June 2021
  9. Glutamate, Glutamatergic Drugs and Schizophrenia

    Over the past two decades, increasing evidence from preclinical and human studies supports a major role of glutamatergic dysfunction in the...
    Carolina Muguruza, Luis F. Callado in Glutamate and Neuropsychiatric Disorders
    Chapter 2022
  10. Evaluation of the effects of the mGlu2/3 antagonist LY341495 on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset

    Background

    We have previously demonstrated that the metabotropic glutamate 2 and 3 (mGlu 2/3 ) antagonist LY341495 reverses the anti-dyskinetic and...

    Stephen G. Nuara, Jim C. Gourdon, Philippe Huot in Pharmacological Reports
    Article 27 June 2022
  11. Partial mGlu5 receptor NAM, M-5MPEP, induces rapid and sustained antidepressant-like effects in the BDNF-dependent mechanism and enhances (R)-ketamine action in mice

    Background

    Partial negative allosteric modulators (NAM) of the metabotropic glutamate 5 (mGlu 5 ) receptor are an excellent alternative to full...

    Agnieszka Pałucha-Poniewiera, Anna Rafało-Ulińska, ... Katarzyna Kaczorowska in Pharmacological Reports
    Article 18 April 2024
  12. Effects of Chronic Combined Treatment with Ketanserin and Fluoxetine in B6.CBA-D13Mit76C Recombinant Mice with Abnormal 5-HT1A Receptor Functional Activity

    Abstract

    The recombinant B6.CBA-D13Mit76C mouse strain is characterized by an altered sensitivity of 5-HT 1A receptors and upregulated 5-HT 1A gene...

    Anton S. Tsybko, Elena M. Kondaurova, ... Vladimir S. Naumenko in Biochemistry (Moscow)
    Article 15 June 2023
  13. Effects of (S)-3,4-DCPG, an mGlu8 receptor agonist, on hippocampal long-term potentiation at perforant pathway-dentate gyrus synapses in prenatal valproic acid-induced rat model of autism

    Autism spectrum disorder (ASD) is a pervasive neurodevelopmental condition characterized by social interaction deficits, communication impairments,...

    Parsa Gholipour, Zahra Ebrahimi, ... Seyed Asaad Karimi in Scientific Reports
    Article Open access 07 June 2024
  14. Biased signaling due to oligomerization of the G protein-coupled platelet-activating factor receptor

    G protein-coupled receptors (GPCRs) are important drug targets that mediate various signaling pathways by activating G proteins and engaging...

    Junke Liu, Hengmin Tang, ... Jianfeng Liu in Nature Communications
    Article Open access 26 October 2022
  15. Optical Approaches for Modulating mGlu Receptor Activity

    The metabotropic glutamate (mGlu) receptor family plays a diverse role in cellular function. However, differentiation of the specific contributions...
    Lauren E. Hood, Jonna M. Leyrer-Jackson, M. Foster Olive in Metabotropic Glutamate Receptor Technologies
    Protocol 2021
  16. Rapastinel alleviates the neurotoxic effect induced by NMDA receptor blockade in the early postnatal mouse brain

    Rapastinel is a novel psychoactive substance that acts as an N-methyl-D-aspartate-receptor (NMDAR) agonist and triggers antidepressant- and...

    Andrei-Nicolae Vasilescu, Anne Mallien, ... Dragos Inta in European Archives of Psychiatry and Clinical Neuroscience
    Article 13 August 2020
  17. Modulation of DOM-Induced Head-Twitch Response by mGluR2 Agonist/Inverse Agonist is Associated with 5-HT2AR-Mediated Gs Signaling Pathway

    Hallucinogenic 5-HT 2A receptor (5-HT 2A R) agonists-induced head-twitch response (HTR) is regulated by G s signaling pathway. Formation of heterodimers...

    Huan Gao, **aoqian Liu, ... Ruibin Su in Neurochemical Research
    Article 21 November 2023
  18. Psychedelics action and schizophrenia

    Psychedelics are compounds acting by serotonin 5-hydroxytryptamine (5-HT) 2A receptor activation and induce several behavioral responses. They are of...

    Marzena Maćkowiak in Pharmacological Reports
    Article Open access 30 October 2023
Did you find what you were looking for? Share feedback.